Alignment Healthcare, Inc.
ALHC Healthcare Healthcare Plans
Alignment Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.9 billion, up 46.1% from fiscal 2024. In the quarter to June 2026, revenue grew 31.6%, EPS grew 125.0%, free cash flow fell 229.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
Follow ALHC
Alignment Healthcare, Inc. (ALHC) Piotroski F-score
Alignment Healthcare, Inc.'s Piotroski F-score for fiscal 2025 is 6 out of 9: 6 of nine tests of profitability, leverage and efficiency passed, up from 5 in fiscal 2024.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 6 | 1.00 |
| FY2024 | 5 | 3.00 |
| FY2023 | 2 | (2.00) |
| FY2022 | 4 | 1.00 |
| FY2021 | 3 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (0.08%) | (18.64%) | Fail | 0 |
| Positive operating cash flow | 139.93m | 34.77m | Pass | 1 |
| Rising return on assets | (0.08%) | (18.64%) | Pass | 1 |
| Cash flow above net income | 140.65m | 162.81m | Pass | 1 |
| Falling long-term leverage | 0.35 | 0.47 | Pass | 1 |
| Rising current ratio | 1.71 | 1.88 | Fail | 0 |
| No new shares issued | 198,006,200 | 190,793,500 | Fail | 0 |
| Rising gross margin | 12.37% | 10.97% | Pass | 1 |
| Rising asset turnover | 4.27 | 3.94 | Pass | 1 |
| Piotroski F-score | Mixed | 6 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| PGNY Progyny, Inc. compare | 8 |
| CI Cigna Group compare | 8 |
| HUM Humana Inc. compare | 6 |
| ALHC Alignment Healthcare, Inc. | 6 |
| ELV Elevance Health, Inc. compare | 6 |
| CNC Centene Corporation compare | 5 |
| MOH Molina Healthcare, Inc compare | 4 |
| CLOV Clover Health Investments, Corp. compare | 3 |
| OSCR Oscar Health, Inc. compare | 3 |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover